NRC Health (NRC) vs SOPHiA GENETICS SA (SOPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
NRC Health (NRC) has outperformed SOPHiA GENETICS SA (SOPH) over the past year, gaining 71.3% versus a gain of 62.9%. Over five years, NRC leads with a -52.4% price change compared with -54.7% for SOPH. SOPHiA GENETICS SA is the larger company by market cap ($621.4 million vs $451.7 million), about 1.4 times the size.
NRC Health pays a dividend yielding 2.94%, while SOPHiA GENETICS SA does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NRC | SOPH |
|---|---|---|
| Share price | $20.42 | $7.30 |
| Market cap | $451.68M | $621.43M |
| 1-day change | +1.14% | +2.10% |
| YTD return | +8.79% | +56.32% |
| 1-year return | +71.31% | +62.95% |
| 5-year return | -52.38% | -54.66% |
| P/E ratio (TTM) | 85.08 | — |
| Forward P/E | 19.45 | — |
| EPS (TTM) | $0.24 | $-1.16 |
| Dividend yield | 2.94% | 0.00% |
| Annual dividend | $0.60 | $0.00 |
| 52-week high | $23.68 | $8.98 |
| 52-week low | $11.01 | $3.75 |
| Distance from 52-week high | -13.77% | -18.71% |
| Analyst consensus | none | none |
| Avg. price target upside | +27.33% | +33.56% |
| Average volume | 115.97K | 549.78K |
| Shares outstanding | 22.12M | 85.13M |
| Employees | 357 | 415 |
| Sector | Health Care | Technology |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | EDP Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- NRC Health offers a meaningfully higher dividend yield (2.94% vs 0.00%).
- The two companies sit in different sectors: NRC Health in Health Care and SOPHiA GENETICS SA in Technology.
About NRC Health
NRC stock →NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments.
Health Care · Biotechnology: Commercial Physical & Biological Resarch · 357 employees
About SOPHiA GENETICS SA
SOPH stock →SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities.
Technology · EDP Services · 415 employees
NRC vs SOPH FAQ
Which is bigger, NRC Health or SOPHiA GENETICS SA?
SOPHiA GENETICS SA (SOPH) is larger, with a market capitalization of $621.43M compared with $451.68M for NRC Health (NRC).
Which stock has performed better over the past year, NRC or SOPH?
NRC returned +71.31% over the past 12 months, compared with +62.95% for SOPH (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, NRC Health or SOPHiA GENETICS SA?
NRC Health pays a dividend yielding 2.94%, while SOPHiA GENETICS SA does not currently pay a regular dividend.
Are NRC Health and SOPHiA GENETICS SA in the same industry?
No. NRC Health is in the Health Care sector, while SOPHiA GENETICS SA is in Technology.